229 related articles for article (PubMed ID: 18211479)
1. Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.
Tuon FF; Amato VS; Graf ME; Siqueira AM; Nicodemo AC; Amato Neto V
Int J Dermatol; 2008 Feb; 47(2):109-24. PubMed ID: 18211479
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mucosal leishmaniasis in Latin America: systematic review.
Amato VS; Tuon FF; Siqueira AM; Nicodemo AC; Neto VA
Am J Trop Med Hyg; 2007 Aug; 77(2):266-74. PubMed ID: 17690398
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Brito NC; Rabello A; Cota GF
PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of localized cutaneous leishmaniasis].
Buffet P; Caumes E; Gentilini M
Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
[No Abstract] [Full Text] [Related]
5. Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review.
Almeida OL; Santos JB
An Bras Dermatol; 2011; 86(3):497-506. PubMed ID: 21738967
[TBL] [Abstract][Full Text] [Related]
6. Leishmaniasis: an update of current pharmacotherapy.
Sundar S; Chakravarty J
Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of visceral leishmaniasis.
Davidson RN; Croft SL
Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
[No Abstract] [Full Text] [Related]
8. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous leishmaniasis].
Enk CD; Gardlo K; Hochberg M; Ingber A; Ruzicka T
Hautarzt; 2003 Jun; 54(6):506-12. PubMed ID: 12759734
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B
Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis: 20 years' experience in a Spanish tertiary care hospital.
Giavedoni P; Iranzo P; Fuertes I; Estrach T; Alsina Gibert M
Actas Dermosifiliogr; 2015 May; 106(4):310-6. PubMed ID: 25678133
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Oliveira LF; Schubach AO; Martins MM; Passos SL; Oliveira RV; Marzochi MC; Andrade CA
Acta Trop; 2011 May; 118(2):87-96. PubMed ID: 21420925
[TBL] [Abstract][Full Text] [Related]
13. New delivery strategies for the old pentavalent antimonial drugs.
Frézard F; Demicheli C
Expert Opin Drug Deliv; 2010 Dec; 7(12):1343-58. PubMed ID: 21029028
[TBL] [Abstract][Full Text] [Related]
14. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment.
Mitropoulos P; Konidas P; Durkin-Konidas M
J Am Acad Dermatol; 2010 Aug; 63(2):309-22. PubMed ID: 20303613
[TBL] [Abstract][Full Text] [Related]
15. Emergency initiative to reduce leishmaniasis in Afghanistan.
Querido J
Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
[No Abstract] [Full Text] [Related]
16. Current treatment approaches to leishmaniasis.
Berman J
Curr Opin Infect Dis; 2003 Oct; 16(5):397-401. PubMed ID: 14501991
[TBL] [Abstract][Full Text] [Related]
17. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
Soto J; Toledo J; Vega J; Berman J
Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
[TBL] [Abstract][Full Text] [Related]
18. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.
Arevalo I; Tulliano G; Quispe A; Spaeth G; Matlashewski G; Llanos-Cuentas A; Pollack H
Clin Infect Dis; 2007 Jun; 44(12):1549-54. PubMed ID: 17516397
[TBL] [Abstract][Full Text] [Related]
19. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
Krause G; Kroeger A
Clin Infect Dis; 1999 Aug; 29(2):466-7. PubMed ID: 10476776
[No Abstract] [Full Text] [Related]
20. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam.
Lai A Fat EJ; Vrede MA; Soetosenojo RM; Lai A Fat RF
Int J Dermatol; 2002 Nov; 41(11):796-800. PubMed ID: 12453009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
